Drug Shortage Report for CLINDAMYCIN INJECTION USP
Report ID | 135622 |
Drug Identification Number | 02230540 |
Brand name | CLINDAMYCIN INJECTION USP |
Common or Proper name | CLINDAMYCIN INJECTION USP |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 150MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 4ML 10LIVI CA |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-03-12 |
Estimated end date | 2021-10-15 |
Actual end date | 2021-09-28 |
Shortage status | Resolved |
Updated date | 2021-09-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-03-15 | English | Compare |
v2 | 2021-03-15 | French | Compare |
v3 | 2021-05-17 | English | Compare |
v4 | 2021-05-17 | French | Compare |
v5 | 2021-06-14 | English | Compare |
v6 | 2021-06-14 | French | Compare |
v7 | 2021-09-28 | English | Compare |
v8 | 2021-09-28 | French | Compare |
v9 | 2021-09-29 | English | Compare |
Showing 1 to 9 of 9